Sogn Arena (map)
Klaus Torgårds vei 3, 2. etg
At the School of health innovation, participants will gain knowledge, tools and networks that will enhance their ability to solve future health challenges and further develop the healthcare system.
– The «moonshot» of my research is to find new therapeutic strategies to cure triple-negative breast cancer that is a challenging disease with the poorest prognosis of all breast cancer subtypes, Enrico Catalano says.
Research from the Morth Group shows that Zinc-binding plays an important role in the sensing and regulation of cellular pH in the human brain. Findings published in Nature Group's Scientific Reports
Jacques Dubochet, Joachim Frank and Richard Henderson awarded Nobel Prize in Chemistry 2017
The annual NLS Days conference took place on 12-14 September at the Malmö Convention Centre in Sweden.
UiO:Life Science plans the launch of the SPARK innovation programme, developed by Stanford University. The goal is to get more innovation out of basic research. The other two European SPARK programs visit Oslo this summer to share their experiences, and one of UiO's PhD students will test the program's summer school in Japan.
The board of UiO:Life Science has decided to support the newly established School of Health Innovation at UiO, NTNU and Karolinska Institutet. With this UiO:Life Science wants to contribute to establish a new strong player in the UiO ecosystem of innovation.
Study published in Cell Reports shows that the accessibility of DNA varies from patient to patient, and may act as a fingerprint for prostate cancer progression.
– My goal is to run personalized computer simulations able to predict the effect of the therapy in a given patient, mathematician Alvaro Köhn-Luque says. He is one of the 82 postdoctoral fellows at the Scientia Fellows programme at the faculty.
Master and PhD students at UiO can apply UiO:Life Science for 3–6 months trainee positions in the life science industry. The application deadline was 1st of June 2017.
Findings from a Centre for Digital Life Norway report into the digitalisation of Norway’s bio economy is unveiled at the Digital Life Conference 2017.
Researchers have found a new method to develop antibiotics that are tailored to kill multi-resistant bacteria.
A collaboration between the MAGIC non-profit research and innovation programme and the British Medical Journal will enable updated treatment guidelines to reach healthcare professionals more quickly.
Researchers at the Faculty have shown that harmful immune cells are more easily activated in patients suffering from the autoimmune disease lupus than in healthy people.
The School of Health Innovation will help new ideas to germinate and be developed more rapidly by our health researchers, and enhance innovative thinking and culture at the Faculty,’ says Hilde Nebb, Pro-Dean.
Interactions between the gut and the body are central to good health. Researchers at the University of Oslo have now identified one of the key regulators of these interactions.
3D-printing of human tissue is no longer Science Fiction, it's a science fact. The Norwegian Center for Stem Cell Research launches The Neuron Factory, a platform that can produce human neurons for research purposes.
It is well known that the drug ASA, also known internationally as Aspirin, has analgesic and fever-reducing properties. However, this drug may also increase the likelihood of surviving colon cancer.
– Clinical guidelines must be built upon a broad evidence base, the UiO professors Eivind Engebretsen and Kristin Heggen state.